{"schema_version":"secwatch.filing_event.v1","accession":"0001528287-21-000013","form_type":"8-K","ticker":"NPCE","cik":"0001528287","company_name":"NeuroPace Inc","filed_at":"2021-09-09T23:59:59+00:00","discovered_at":"2026-05-14T18:04:18.456843+00:00","generated_at":"2026-06-29T04:49:07.604427+00:00","sec_items":["7.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"NeuroPace warns Q3 revenue uncertainty due to COVID-19 Delta variant procedure delays","bullets":["Procedure volumes impacted in Q3 due to scheduling delays from COVID-19 Delta variant.","Management believes delays will create uncertainty around revenue for second half of 2021.","Company to participate in three healthcare conferences: Wells Fargo, Morgan Stanley, Baird."],"urls":{"canonical":"https://secwatch.observer/filing/0001528287-21-000013","json":"https://secwatch.observer/filing/0001528287-21-000013.json","markdown":"https://secwatch.observer/filing/0001528287-21-000013.md","text":"https://secwatch.observer/filing/0001528287-21-000013.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1528287/000152828721000013/0001528287-21-000013-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1528287/000152828721000013/npce-20210909.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-29T04:49:07.604427+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}